Proceedings: On antifibrillatory properties of cardiac glycosides.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004558:Electric Stimulation; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D010042:Ouabain / Q000627:therapeutic use; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D010042:Ouabain; D004077:Digoxin; D004074:Digitoxin